Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer (Q45240527)

11 December 2017

Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer (English)

1 reference

11 December 2017

0 references

Dimitrios Iliopoulos

1

1 reference

11 December 2017

Gulnur Guler

2

1 reference

11 December 2017

Shuang-Yin Han

3

1 reference

11 December 2017

Danika Johnston

4

1 reference

11 December 2017

Teresa Druck

5

1 reference

11 December 2017

Kelly A McCorkell

6

1 reference

11 December 2017

Juan Palazzo

7

1 reference

11 December 2017

Peter A McCue

8

1 reference

11 December 2017

Raffaele Baffa

9

1 reference

11 December 2017

Kay Huebner

10

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 December 2017

1 reference

11 December 2017

24

1 reference

11 December 2017

9

1 reference

11 December 2017

1625-1633

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1208398

11 December 2017

0 references

cites work

Loss of FHIT expression in transitional cell carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

DNA methylation in haematological malignancies: the role of decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

Cancer and the FRA3B/FHIT fragile locus: it's a HIT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

Alterations of common chromosome fragile sites in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

WWOX: a candidate tumor suppressor gene involved in multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

7 January 2021

The role of the FHIT/FRA3B locus in cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

7 January 2021

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

7 January 2021

Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1208398

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1208398

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference